Histocompatibility Laboratories - Supplier Compliance with Payment Requirements
Histocompatibility laboratories typically provide testing required for bone marrow and solid organ transplantation services. Cost information for these laboratories must be accurate and in sufficient detail to support payments made for services provided (42 CFR § 413.24(a) and (c)). Costs claimed in the cost report must be related to the care of beneficiaries; reasonable, necessary, and proper; and allowable under Medicare regulations (42 CFR § 413.9(a), (b), and (c)(3)). From March 31, 2013, through September 30, 2014, histocompatibility laboratories reported $131 million in reimbursable costs on their most recent cost reports. We will determine whether payments to histocompatibility laboratories were made in accordance with Medicare requirements.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|Nov-16||Centers for Medicare & Medicaid Services||Histocompatibility Laboratories - Supplier Compliance with Payment Requirements||Office of Audit Services||W-00-16-35742||2018|